Skip to content

Effect of Micronutrients and Life Skills Education on the Health and Nutrition of Adolescent and Young Women in Pakistan

Prospective, Cluster Randomized Effectiveness Trial of Multiple Micronutrient Supplementation and Life Skills Education Provided From Preconception on Health and Nutrition Outcomes of Young, Reproductive-age Pakistani Women (15-24 Years)

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03287882
Enrollment
25447
Registered
2017-09-19
Start date
2017-06-30
Completion date
2022-02-28
Last updated
2021-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents, Anemia, Empowerment, Pregnancy

Keywords

preconception supplementation, multiple micronutrients, low birth weight

Brief summary

The primary aims of this study are: 1) To evaluate the impact of supplementation with multiple micronutrients (MMN) from preconception and life skills education among women 15-18.9 years of age at enrolment on the prevalence of anemia in a population setting; and 2) To evaluate the impact of supplementation with MMN from preconception and life skills education among young women 15-24 years of age on the rate of low birth weight (LBW) in a population setting. Infants born to mothers enrolled in the study will be followed for 1 year. This study aims to enrol 25,400 non-pregnant young women in Matiari district. This sample size is anticipated to equate to 1456 births. Participants will be randomized by cluster to receive either MMN supplements and life skills education or the standard of care at enrolment. Clusters have been defined based on health facility catchment areas. MMN supplements will be provided twice weekly during the preconception period, once daily during the pregnancy period, and once daily until 6 months after giving birth during the postpartum period; and a package of life skills education materials will be provided bi-monthly during the preconception period. In addition to the primary outcomes, measurements will include micronutrient status, anthropometrics, birth outcomes, dietary intake and feeding practices, adherence, and indices of empowerment.

Interventions

The intervention is an oral tablet containing 15 different vitamins and minerals at the UNIMMAP composition (includes 30 mg iron, 400 μg folic acid, 15 mg zinc, 2 mg copper, 65 μg selenium, 800 μg RE vitamin A, 1.4 mg vitamin B1, 1.4 mg vitamin B2, 18 mg niacin, 1.9 mg vitamin B6, 2.6 μg vitamin B12, 70 mg vitamin C, 5 μg vitamin D, 10 mg vitamin E and 150 μg iodine). Each tablet is small (approximately 10 mm diameter) and has been procured using the UNICEF supply catalogue. A single MMN supplementation dose will consist of a single tablet.

BEHAVIORALLife skills based education

The life skills based education will be provided bi-monthly in the format of a group session throughout the preconception period. Three topic areas related to empowerment have been prioritized, including preventing early marriage; personal and menstrual hygiene practices; and the importance of nutrition to good health. Integrated within these topics will be messages related to the importance of continuing one's education, mental health, gender norms and equality, decision making, advocacy, resiliency, participation, communication skills, facing challenges, agency, conflict resolution, and the prevention of violence.

Sponsors

The Hospital for Sick Children
CollaboratorOTHER
National Program for Family Planning and Primary Health Care
CollaboratorUNKNOWN
Bill and Melinda Gates Foundation
CollaboratorOTHER
Aga Khan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Some investigators are blinded to the allocation of the intervention, and all study data collectors are blinded.

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Minimum age at enrolment: 15 years * Maximum age at enrolment: 23 years * Any marital status * Intend to comply with study intervention and follow up

Exclusion criteria

* Women participating in other nutrition trials * Women who intend to leave the study area * Women who are already pregnant

Design outcomes

Primary

MeasureTime frameDescription
Anemia status0, 12*, 24 months (*in subgroup only)Hemoglobin concentration \<12 g/dL
Low birth weightAt birthBirth weight \<2500 g

Secondary

MeasureTime frame
Anthropometrics: middle upper arm circumference (women)Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months
Anthropometrics: weight (women)Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months
Gestational ageAt birth
Preterm birthAt birth
StillbirthAt birth
Small for gestational ageAt birth
Birth size: lengthWithin 24 hours of birth
Birth size: head circumferenceWithin 24 hours of birth
Birth size: middle upper arm circumferenceWithin 24 hours of birth
Biomarkers: serum ferritin, serum transferrin receptor, hepcidin, serum retinol, serum 25(OH)D, alpha-glycolytic protein, C-reactive protein (women)Preconception (subgroup only): enrolment, 1 year, 2 years; Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week
Birth defectsAt birth
Infant growth: length1, 3, 6, 9, 12 months
Infant growth: head circumference1, 3, 6, 9, 12 months
Infant growth: middle upper arm circumference1, 3, 6, 9, 12 months
Infant growth: weight1, 3, 6, 9, 12 months
Age at marriageEnrolment, 1 year, 2 years
Completion of 10th grade educationEnrolment, 1 year, 2 years
Use of sanitary pad during last menstrual periodEnrolment, 1 year, 2 years
Dietary intake: 24-hour recall (subgroup of women)Preconception: enrolment; Pregnancy: 4-12 weeks, 32 weeks
Birth size: weightWithin 24 hours of birth
Anthropometrics: height (women)Preconception: enrolment, 6 months*, 1 year, 2 years (*in subgroup only); Pregnancy: 4-12 weeks, 32 weeks; Postpartum: 1 week, 6 months

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026